Norris Medicines will hold a meeting of the Board of Directors of the Company on 14 November 2025.Powered by Capital Market - Live News

Norris Medicines announced that the 34th Annual General Meeting(AGM) of the company will be held on 29 September 2025.Powered by Capital Market - Live News

Net Loss of Norris Medicines reported to Rs 0.31 crore in the quarter ended June 2025 as against net loss of Rs 0.37 crore during the previous quarter ended June 2024. Sales rose 102.78% to Rs 1.46 crore in the quarter ended June 2025 as against Rs 0.72 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales1.460.72 103 OPM %-6.85-23.61 - PBDT-0.19-0.24 21 PBT-0.31-0.37 16 NP-0.31-0.37 16 Powered by Capital Market - Live News

Norris Medicines will hold a meeting of the Board of Directors of the Company on 14 August 2025.Powered by Capital Market - Live News

Net loss of Norris Medicines reported to Rs 0.23 crore in the quarter ended March 2025 as against net profit of Rs 0.17 crore during the previous quarter ended March 2024. Sales rose 82.55% to Rs 2.72 crore in the quarter ended March 2025 as against Rs 1.49 crore during the previous quarter ended March 2024.For the full year,net loss reported to Rs 1.24 crore in the year ended March 2025 as against net loss of Rs 1.19 crore during the previous year ended March 2024. Sales rose 3.19% to Rs 5.82 crore in the year ended March 2025 as against Rs 5.64 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales2.721.49 83 5.825.64 3 OPM %2.5732.21 --4.47-3.37 - PBDT-0.030.40 PL -0.64-0.53 -21 PBT-0.170.26 PL -1.18-1.10 -7 NP-0.230.17 PL -1.24-1.19 -4 Powered by Capital Market - Live News